JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 9, 2008; DOI: 10.1124/jpet.107.132977

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.132977v1
325/1/302    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, K. J
Right arrow Articles by Damaj, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, K. J
Right arrow Articles by Damaj, M. I.


Received for publication October 17, 2007.
Revised January 8, 2008.
Accepted for publication January 8, 2008.

Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs

Kia J Jackson 1, Billy R. Martin 2, Jean-Pierre Changeux 3, M. Imad Damaj 4*

1 Virginia Commonwealth University 2 Med. Coll. of Virginia, VA Commonwealth Univ. 3 Pasteur Institute 4 Medical College of Virginia

* Address correspondence to: E-mail: mdamaj{at}vcu.edu

Abstract

It has been suggested that the negative effects associated with nicotine withdrawal promote continued tobacco use and contribute to the high relapse rate of smoking behaviors. Thus, it is important to understand the receptor-mediated mechanisms underlying nicotine withdrawal to aid in the development of more successful smoking cessation therapies. The effects of nicotine withdrawal are mediated through nAChRs; however the role of the different nAChRs subtypes in nicotine withdrawal remains unclear. Therefore, we used mecamylamine-precipitated, spontaneous, and conditioned place aversion withdrawal models to measure physical and affective signs of nicotine withdrawal in various nAChR knock-out mice. {beta}2, {alpha}7, and {alpha}5 nAChR knock-out male mice were chronically exposed to nicotine through surgically implanted osmotic mini pumps and 14 days later they were assessed for withdrawal signs. Our results show a loss of affective signs of withdrawal such as anxiety-related behavior and aversion in {beta}2 knock-out mice, while {alpha}7 and {alpha}5 knock-out mice displayed a loss of physical withdrawal signs such as hyperalgesia and somatic signs respectively. These results suggest that {beta}2-containing nAChRs are involved in the affective signs of nicotine withdrawal, while non-{beta}2 containing nAChRs are more closely associated with physical signs of nicotine withdrawal; thus the nAChR subtype composition plays an important role in the development of nicotine withdrawal.


Key words: affective, mice, nicotine, place averson, somatic, withdrawal


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
L. L. Merritt, B. R. Martin, C. Walters, A. H. Lichtman, and M. I. Damaj
The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 483 - 492.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.